Photosensitized co-generation of nitric oxide and singlet oxygen enhanced toxicity against ovarian cancer cells
Source abstract
Abstract
Near micromolar concentrations of nitric oxide (NO) induce tumor cells death. However, an appropriate NO load has to be delivered selectively to the tumor site in order to avoid NO loss and secondary NO-induced effects. The encapsulation of millimolar concentrations of a NO source and an appropriate trigger of NO release within phospatidylcholine-based liposomes should provide an efficient tool for the selective release of the needed NO payload. In this work we report the photosensitized generation of singlet oxygen and NO from folate-targeted PEGylated liposomes, containing AlPcS4 as the sensitizer and S-nitrosoglutathione (GSNO), in millimolar amounts, as the NO source. Amounts of singlet oxygen detected outside the liposome when using PEGylated liposomes are near 200 % larger when GSNO is present inside the liposomes as compared to its absence. These liposomes, conjugated to folate, were found to enhance the photosensitized cytotoxicity to A2780CP20 ovarian cancer cells as compared to liposomes containing the sensitizer but no GSNO (30 % as compared to 70 % cell viability) under the conditions of this work. Fluorescense of AlPcS4 was observed inside cells incubated with folate-conjugated liposomes but not with liposomes without folate. The photosensitized activity enhancement by GSNO increased when light fluence or liposome concentration were increased. The majority of ovarian cancer patients are initially diagnosed with disseminated intra-abdominal disease (stages III-IV) and have a 5-year survival of less than 20%. This work suggests a novel ovarian cancer nodules treatment via the use of tumor-targeted liposome nanoparticles with the capability of generating simultaneously reactive oxygen and nitrogen species upon illumination with near-infrared light.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Cancer, Hypoxia, and Metabolism
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (68)
Show source-provided references
1. Al-Nasiry S, Geusens N, Hanssens M, Luyten C, Pijnenborg R (2007) The use of Alamar Blue assay for quantitative analysis of viability, migration and invasion of choriocarcinoma cells. Hum Reprod 22:1304–130910.1093/humrep/dem011 ↗
2. Aygun A, Torrey K, Kumar A, Stephenson LD (2012) Investigation of factors affecting controlled release from photosensitive DMPC and DSPC liposomes. Appl Biochem Biotech 167:743–75710.1007/s12010-012-9724-6 ↗
3. Azaïs H, Schmitt C, Tardivel M, Kerdraon O, Stallivieri A, Frochot C et al (2016) Assessment of the specificity of a new folate-targeted photosensitizer for peritoneal metastasis of epithelial ovarian cancer to enable intraperitoneal photodynamic therapy. A Preclinical Study Photodiagnosis Photodyn Ther 13:130–13810.1016/j.pdpdt.2015.07.005 ↗
4. Azaïs H, Estevez JP, Foucher PP, Kerbage Y, Mordon S, Collinet P et al (2017) Dealing with microscopic peritoneal metastases of epithelial ovarian cancer. A Surgical Challenge Surg Oncol 26:46–5210.1016/j.suronc.2017.01.001 ↗
5. Báez-Vega PM, Vargas IM, Valiyeva F, Rosado JE, Roman A, Flores J et al (2016) Targeting miR-21-3p inhibits proliferation and invasion of ovarian cancer cells. Oncotarget 7:3632110.18632/oncotarget.9216 ↗
6. Baydoun M, Moralès O, Frochot C, Ludovic C, Leroux B, Thecua E et al (2020) Photodynamic therapy using a new folate receptor-targeted photosensitizer on peritoneal ovarian cancer cells induces the release of extracellular vesicles with immunoactivating properties. J Clin Med 9:118510.3390/jcm9041185 ↗
7. Bonavida B, Baritaki S, Huerta-Yepez S, Vega MI, Chatterjee D, Yeung K (2008) Novel therapeutic applications of nitric oxide donors in cancer: roles in chemo-and immunosensitization to apoptosis and inhibition of metastases. Nitric Oxide 19:152–15710.1016/j.niox.2008.04.018 ↗
8. Bovis MJ, Woodhams JH, Loizidou M, Scheglmann D, Bown SG, MacRobert AJ (2012) Improved in vivo delivery of m-THPC via pegylated liposomes for use in photodynamic therapy. J Control Release 157:196–20510.1016/j.jconrel.2011.09.085 ↗
9. Chiu SM, Xue LY, Lam M, Rodriguez ME, Zhang P, Kenney ME et al (2010) A requirement for bid for induction of apoptosis by photodynamic therapy with a lysosome- but not a mitochondrion-targeted photosensitizer. Photochem Photobiol 86:1161–117310.1111/j.1751-1097.2010.00766.x ↗
10. Coelho C, Guyot G, Ter Halle A, Cavani L, Ciavatta C, Richard C (2011) Photoreactivity of humic substances: relationship between fluorescence and singlet oxygen production. Environ Chem Lett 9:447–45110.1007/s10311-010-0301-3 ↗
11. Colussi VC, Feyes DK, Mulvihill JW, Li Y-S, Kenney ME, Elmets CA et al (1999) Phthalocyanine 4 (Pc 4) Photodynamic therapy of human OVCAR-3 tumor xenografts. Photochem Photobiol 69:236–24110.1111/j.1751-1097.1999.tb03280.x ↗
12. Dadashzadeh S, Vali AM, Rezaie M (2008) The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats. Int J Pharm 353:251–25910.1016/j.ijpharm.2007.11.030 ↗
13. Deng Y, Jia F, Chen S, Shen Z, Jin Q, Fu G, Ji J (2018) Nitric oxide as an all-rounder for enhanced photodynamic therapy: Hypoxia relief, glutathione depletion and reactive nitrogen species generation. Biomater 187:55–6510.1016/j.biomaterials.2018.09.043 ↗
14. Derycke ASL, de Witte PAM (2004) Liposomes for photodynamic therapy. Adv Drug Deliv Rev 56:17–3010.1016/j.addr.2003.07.014 ↗
15. Di Nicola M, Williams Jr BK, Hua J, Bekerman VP, Mashayekhi A, Shields, JA et al. (2022) Photodynamic therapy (PDT) for retinal hemangioblastoma: treatment outcomes in 17 consecutive patients. Ophthalmol Retina 6:80–8810.1016/j.oret.2021.04.007 ↗
16. Dias LM, Sharifi F, de Keijzer MJ, Mesquita B, Desclos E, Kochan JA et al (2021) Attritional evaluation of lipophilic and hydrophilic metallated phthalocyanines for oncological photodynamic therapy. J Photochem Photobiol B: Biol 216:11214610.1016/j.jphotobiol.2021.112146 ↗
17. Echevarría-Vargas IM, Valiyeva F, Vivas-Mejía PE (2014) Upregulation of miR-21 in cisplatin resistant ovarian cancer via JNK-1/c-Jun pathway. PLoS One 9:e9709410.1371/journal.pone.0097094 ↗
18. Fabregat V, Burguete MI, Galindo F, Luis SV (2014) Singlet oxygen generation by photoactive polymeric microparticles with enhanced aqueous compatibility. Environ Sci Pollut R 21:11884–1189210.1007/s11356-013-2311-8 ↗
19. Fernandez JM, Bilgin MD, Grossweiner LI (1997) Singlet oxygen generation by photodynamic agents. J Photochem Photobiol B 37:131–14010.1016/S1011-1344(96)07349-6 ↗
20. Filonenko EV, Sokolov VV, Chissov VI, Lukyanets EA, Vorozhtsov GN (2008) Photodynamic therapy of early esophageal cancer. Photodiagnosis Photodyn Ther 5:187–19010.1016/j.pdpdt.2008.06.001 ↗
21. Firsov AM, Kotova EA, Antonenko YN (2018) Calcein leakage as a robust assay for cytochrome c/H 2 O 2–mediated liposome permeabilization. Anal Biochem 52:19–2310.1016/j.ab.2017.03.014 ↗
22. Gabizon AA, Shmeeda H, Zalipsky S (2006) Pros and cons of the liposome platform in cancer drug targeting. J Liposome Res 16:175–18310.1080/08982100600848769 ↗
23. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982) Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 126:131–13810.1016/0003-2697(82)90118-X ↗
24. Hart TW (1985) Some observations concerning the s-nitroso and s-phenylsulphonyl derivatives of l-cysteine and glutathione. Tetrahedron Let 26:2013–201610.1016/S0040-4039(00)98368-0 ↗
25. Hashizaki K, Taguchi H, Itoh C, Sakai H, Abe M, Saito Y et al (2003) Effects of poly (ethylene glycol)(PEG) chain length of PEG-lipid on the permeability of liposomal bilayer membranes. Chem Pharm Bull (tokyo) 51:815–82010.1248/cpb.51.815 ↗
26. Heinrich TA, Tedesco AC, Fukuto JM, da Silva RS (2014) Production of reactive oxygen and nitrogen species by light irradiation of a nitrosyl phthalocyanine ruthenium complex as a strategy for cancer treatment. Dalton Trans 43:4021–402510.1039/C3DT52217B ↗
27. Hu Z, Rao B, Chen S, Duanmu J (2010) Targeting tissue factor on tumour cells and angiogenic vascular endothelial cells by factor VII-targeted verteporfin photodynamic therapy for breast cancer in vitro and in vivo in mice. BMC Cancer 10:23510.1186/1471-2407-10-235 ↗
28. Huang Z, Fu J, Zhang Y (2017) Nitric oxide donor-based cancer therapy: advances and prospects. J Med Chem 60:7617–763510.1021/acs.jmedchem.6b01672 ↗
29. Ji Y, Akerboom TP, Sies H, Thomas JA (1999) S-nitrosylation and S-glutathiolation of protein sulfhydryls by S-nitroso glutathione. Arch Biochem Biophys 362:67–7810.1006/abbi.1998.1013 ↗
30. Juzenas P, Juzeniene A, Rotomskis R, Moan J (2004a) Spectroscopic evidence of monomeric aluminium phthalocyanine tetrasulphonate in aqueous solutions. J Photochem Photobiol, B 75:107–11010.1016/j.jphotobiol.2004.05.011 ↗
31. Juzenas P, Juzeniene A, Rotomskis R, Moan J (2004b) Spectroscopic evidence of monomeric aluminium phthalocyanine tetrasulphonate in aqueous solutions. J Photochem Photobiol B 75:107–11010.1016/j.jphotobiol.2004.05.011 ↗
32. Kang SH, Chung BY, Park JE, Jeon J, Park YD (2020) Activatable red emitting fluorescent probe for rapid and sensitive detection of intracellular peroxynitrite. Talanta 217:12105310.1016/j.talanta.2020.121053 ↗
33. Logan LPH, Gummet PA, Misiewicz JJ, Karim QN, Walker MM, Baron GH (1991) One week erradication regime for Helicobacter pylori. Lancet 11:1449–1452
34. Luan S, Tran NT, Xue HY, Wong HL (2021) Development of a high payload, cancer-targeting liposomes of methyl aminolevulinate for intraoperative photodynamic diagnosis/therapy of peritoneal carcinomatosis. Int J Pharm 602:12061210.1016/j.ijpharm.2021.120612 ↗
35. Ma J, Wu H, Li Y, Liu Z, Liu G, Guo Y et al (2018) Novel core-interlayer-shell DOX/ZnPc Co-loaded MSNs@ pH-sensitive CaP@ PEGylated liposome for enhanced synergetic chemo-photodynamic therapy. Pharm Res 35:1–1210.1007/s11095-017-2295-z ↗
36. Maniatis T, Fritsch EF, Sambrook J (1982) Molecular cloning. A laboratory manual. Cold Spring Harbor Laboratory Press, New York, pp 466–467
37. McCord JM, Fridovich I (1969) Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 244:6049–605510.1016/S0021-9258(18)63504-5 ↗
38. Misko TP, Schilling RJ, Salvemini D, Moore WM, Currie MG (1993) A fluorometric assay for the measurement of nitrite in biological samples. Anal Biochem 214:11–1610.1006/abio.1993.1449 ↗
39. Mocellin S, Bronte V, Nitti D (2007) Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities. Med Res Rev 27:317–35210.1002/med.20092 ↗
40. Muntané J, Angel J, Marín LM, Padillo FJ (2013) Nitric oxide and cell death in liver cancer cells. Mitochondrion 13:257–26210.1016/j.mito.2012.09.004 ↗
41. Negri LB, Martins TJ, da Silva RS, Hamblin MR (2019) Photobiomodulation combined with photodynamic therapy using ruthenium phthalocyanine complexes in A375 melanoma cells: Effects of nitric oxide generation and ATP production. J Photochem Photobiol B: Biol 198:11156410.1016/j.jphotobiol.2019.111564 ↗
42. New RRC (1990) Liposomes: a practical approach. In: Rickwood HB, D. D, (eds) The Practical Approach Series. Oxford University Press, New York, pp 44–48
43. Nwogu C, Kloc A, Attwood K, Bshara W, Durrani F, Pandey R (2021) Porfimer sodium versus PS785 for photodynamic therapy (PDT) of Lung Cancer Xenografts in Mice (a novel agent for lung cancer PDT). J Surg Res 263:245–25010.1016/j.jss.2020.12.067 ↗
44. O’Dwyer PJ, Hamilton TC, Young RC, LaCreta FP, Carp N, Tew KD et al (1992) Depletion of glutathione in normal and malignant human cells in vivo by buthionine sulfoximine: clinical and biochemical results. J Natl Cancer Inst 84:264–26710.1093/jnci/84.4.264 ↗
45. Paul B, Rajaputra P, You Y (2011) In vitro and in vivo photodynamic activity of core-modified porphyrin IY69 using 690 nm diode laser. Photochem Photobiol 87:1468–147310.1111/j.1751-1097.2011.00988.x ↗
46. Pogue BW, O’Hara JA, Demidenko E, Wilmot CM, Goodwin IA, Chen B et al (2003) Photodynamic therapy with verteporfin in the radiation-induced fibrosarcoma-1 tumor causes enhanced radiation sensitivity. Cancer Res 63:1025–1033
47. Qualls MM, Thompson DH (2001) Chloroaluminum phthalocyanine tetrasulfonate delivered via acid-labile diplasmenylcholine-folate liposomes: intracellular localization and synergistic phototoxicity. Int J Cancer 93:384–39210.1002/ijc.1339 ↗
48. Quiñones-Díaz BI, Reyes-González JM, Sánchez-Guzmán V, Conde-Del Moral I, Valiyeva F, Santiago-Sánchez GS et al (2020) MicroRNA-18a-5p suppresses tumor growth via targeting matrix metalloproteinase-3 in cisplatin-resistant ovarian cancer. Front Oncol 10:288710.3389/fonc.2020.602670 ↗
49. Rak J, Pouckova P, Benes J, Vetvicka D (2019) Drug delivery systems for phthalocyanines for photodynamic therapy. Anticancer Res 39:3323–333910.21873/anticanres.13475 ↗
50. Rapozzi V, Della Pietra E, Zorzet S, Zacchigna M, Bonavida B, Xodo LE (2013) Nitric oxide-mediated activity in anti-cancer photodynamic therapy. Nitric Oxide 30:26–3510.1016/j.niox.2013.01.002 ↗
51. Reyes-González JM, Quiñones-Díaz BI, Santana Y, Báez-Vega PM, Soto D, Valiyeva F et al (2020) Downstream effectors of ILK in cisplatin-resistant ovarian cancer. Cancers 12:88010.3390/cancers12040880 ↗
52. Rizvi I, Anbil S, Alagic N, Celli JP, Zheng LZ, Palanisami A et al (2013) PDT dose parameters impact tumoricidal durability and cell death pathways in a 3D ovarian cancer model. Photochem Photobiol 89:942–95210.1111/php.12065 ↗
53. Shen Z, Ma Q, Zhou X, Zhang G, Hao G, Sun Y et al (2021) Strategies to improve photodynamic therapy efficacy by relieving the tumor hypoxia environment. NPG Asia Mater 13:1–1910.1038/s41427-021-00303-1 ↗
54. Shi Z, Meng X, Zhang K, Tang S, Zhang C, Yang Z et al (2021) Engineering structural metal–organic framework for hypoxia-tolerant type I photodynamic therapy against hypoxic cancer. ACS Mater Lett 3:781–78910.1021/acsmaterialslett.1c00178 ↗
55. Sibata CH, Colussi VC, Oleinick NL, Kinsella TJ (2001) Photodynamic therapy in oncology. Expert Opin Pharmacother 2:917–92710.1517/14656566.2.6.917 ↗
56. Singh RJ, Hogg N, Joseph J, Kalyanaraman B (1995) Photosensitized decomposition of S-nitrosothiols and 2-methyl-2-nitrosopropane. Possible use for site-directed nitric oxide production. FEBS Lett 360:47–5110.1016/0014-5793(95)00065-H ↗
57. Singh RJ, Hogg N, Joseph J, Kalyanaraman B (1996) Mechanism of nitric oxide release from S-nitrosothiols. J Biol Chem 271:18596–1860310.1074/jbc.271.31.18596 ↗
58. Smyth DG, Nagamatsu A, Fruton JS (1960) Some reactions of N-ethylmaleimide1. J Am Chem Soc 82:4600–460410.1021/ja01502a039 ↗
59. Sood AK, Seftor EA, Fletcher MS, Gardner LMG, Heidger PM, Buller RE et al (2001) Molecular determinants of ovarian cancer plasticity. Am J Pathol 158:1279–128810.1016/S0002-9440(10)64079-5 ↗
60. Timmermans M, Sonke GS, Van de Vijver KK, Van der Aa MA, Kruitwagen R (2018) No improvement in long-term survival for epithelial ovarian cancer patients: a population-based study between 1989 and 2014 in the Netherlands. Eu J Cancer 88:31–3710.1016/j.ejca.2017.10.030 ↗
61. Tomasova L, Misak A, Kurakova L, Grman M, Ondrias K (2020) Characterization of Rat Cardiovascular System by Anacrotic/Dicrotic Notches in the Condition of Increase/Decrease of NO Bioavailability. Int J Mol Sci 21:668510.3390/ijms21186685 ↗
62. Torchilin VP (2012) Multifunctional Nanocarriers. Adv Drug Delivery Rev 64:302–31510.1016/j.addr.2012.09.031 ↗
63. Trushina OI, Novikova EG, Sokolov VV, Filonenko EV, Chissov VI, Vorozhtsov GN (2008) Photodynamic therapy of virus-associated precancer and early stages cancer of cervix uteri. Photodiagnosis Photodyn Ther 5:256–25910.1016/j.pdpdt.2008.09.005 ↗
64. Urakami H, Zhang K, Vilela F (2013) Modification of conjugated microporous poly-benzothiadiazole for photosensitized singlet oxygen generation in water. Chem Commun 49:2353–235510.1039/c3cc38956a ↗
65. Wan S-S, Zeng J-Y, Cheng H, Zhang X-Z (2018) ROS-induced NO generation for gas therapy and sensitizing photodynamic therapy of tumor. Biomaterials 185:51–6210.1016/j.biomaterials.2018.09.004 ↗
66. Wen Y, Graybill WS, Previs RA, Hu W, Ivan C, Mangala LS et al (2015) Immunotherapy targeting folate receptor induces cell death associated with autophagy in ovarian cancer. Clin Cancer Res 21:448–45910.1158/1078-0432.CCR-14-1578 ↗
67. Xiang H-J, Deng Q, An L, Guo M, Yang S-P, Liu J-G (2016) Tumor cell specific and lysosome-targeted delivery of nitric oxide for enhanced photodynamic therapy triggered by 808 nm near-infrared light. Chem Commun 52:148–15110.1039/C5CC07006F ↗
68. Xie Y, Ye L, Zhang X, Cui W, Lou J, Nagai T et al (2005) Transport of nerve growth factor encapsulated into liposomes across the blood–brain barrier: In vitro and in vivo studies. J Control Release 105:106–11910.1016/j.jconrel.2005.03.005 ↗